392 related articles for article (PubMed ID: 25732824)
1. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.
Zhang D; Wang Y; Shi Z; Liu J; Sun P; Hou X; Zhang J; Zhao S; Zhou BP; Mi J
Cell Rep; 2015 Mar; 10(8):1335-48. PubMed ID: 25732824
[TBL] [Abstract][Full Text] [Related]
2. miR-9-5p regulates immunometabolic and epigenetic pathways in β-glucan-trained immunity via IDH3α.
Su H; Liang Z; Weng S; Sun C; Huang J; Zhang T; Wang X; Wu S; Zhang Z; Zhang Y; Gong Q; Xu Y
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986196
[TBL] [Abstract][Full Text] [Related]
3. Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis.
Zeng L; Morinibu A; Kobayashi M; Zhu Y; Wang X; Goto Y; Yeom CJ; Zhao T; Hirota K; Shinomiya K; Itasaka S; Yoshimura M; Guo G; Hammond EM; Hiraoka M; Harada H
Oncogene; 2015 Sep; 34(36):4758-66. PubMed ID: 25531325
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
5. The role of NAD(+)-dependent isocitrate dehydrogenase 3 subunit α in AFB1 induced liver lesion.
Yang C; Fan J; Zhuang Z; Fang Y; Zhang Y; Wang S
Toxicol Lett; 2014 Jan; 224(3):371-9. PubMed ID: 24211421
[TBL] [Abstract][Full Text] [Related]
6. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
7. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.
Sica V; Bravo-San Pedro JM; Izzo V; Pol J; Pierredon S; Enot D; Durand S; Bossut N; Chery A; Souquere S; Pierron G; Vartholomaiou E; Zamzami N; Soussi T; Sauvat A; Mondragón L; Kepp O; Galluzzi L; Martinou JC; Hess-Stumpp H; Ziegelbauer K; Kroemer G; Maiuri MC
Cell Rep; 2019 Apr; 27(3):820-834.e9. PubMed ID: 30995479
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer.
Becker LM; O'Connell JT; Vo AP; Cain MP; Tampe D; Bizarro L; Sugimoto H; McGow AK; Asara JM; Lovisa S; McAndrews KM; Zielinski R; Lorenzi PL; Zeisberg M; Raza S; LeBleu VS; Kalluri R
Cell Rep; 2020 Jun; 31(9):107701. PubMed ID: 32492417
[TBL] [Abstract][Full Text] [Related]
9. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
Kumar S; Donti TR; Agnihotri N; Mehta K
Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
[TBL] [Abstract][Full Text] [Related]
11. Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity.
Tello D; Balsa E; Acosta-Iborra B; Fuertes-Yebra E; Elorza A; Ordóñez Á; Corral-Escariz M; Soro I; López-Bernardo E; Perales-Clemente E; Martínez-Ruiz A; Enríquez JA; Aragonés J; Cadenas S; Landázuri MO
Cell Metab; 2011 Dec; 14(6):768-79. PubMed ID: 22100406
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.
Shao S; Zhao L; An G; Zhang L; Jing X; Luo M; Li W; Meng D; Ning Q; Zhao X; Lei J
FASEB J; 2020 Aug; 34(8):10860-10870. PubMed ID: 32592239
[TBL] [Abstract][Full Text] [Related]
13. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.
Dupuy F; Tabariès S; Andrzejewski S; Dong Z; Blagih J; Annis MG; Omeroglu A; Gao D; Leung S; Amir E; Clemons M; Aguilar-Mahecha A; Basik M; Vincent EE; St-Pierre J; Jones RG; Siegel PM
Cell Metab; 2015 Oct; 22(4):577-89. PubMed ID: 26365179
[TBL] [Abstract][Full Text] [Related]
14. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers.
Domingo-Vidal M; Whitaker-Menezes D; Mollaee M; Lin Z; Tuluc M; Philp N; Johnson JM; Zhan T; Curry J; Martinez-Outschoorn U
Front Oncol; 2022; 12():906494. PubMed ID: 35814364
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
[TBL] [Abstract][Full Text] [Related]
17. Lactate preconditioning promotes a HIF-1α-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts.
Kozlov AM; Lone A; Betts DH; Cumming RC
Sci Rep; 2020 May; 10(1):8388. PubMed ID: 32433492
[TBL] [Abstract][Full Text] [Related]
18. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
20. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis.
Zhao L; Li W; Zhou Y; Zhang Y; Huang S; Xu X; Li Z; Guo Q
Free Radic Biol Med; 2015 May; 82():29-41. PubMed ID: 25656992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
